Mirte Scheper

miRNAs and isomiRs: Serum-Based Biomarkers for the Development of Intellectual Disability and Autism Spectrum Disorder in Tuberous Sclerosis Complex

J. D. Mills, L. Lagae, E. Aronica, 2022, Biomedicines.

Dysregulation of miR‐543 in Parkinson's disease: Impact on the neuroprotective gene SIRT1

J. D. Mills, E. Aronica, J. Anink, 2022, Neuropathology and applied neurobiology.

Levamisole suppresses activation and proliferation of human T cells by the induction of a p53-dependent DNA damage response

R. Hoebe, J. Guikema, S. Florquin, 2023, bioRxiv.

Is tuberous sclerosis complex-associated autism a preventable and treatable disorder?

L. Emberti Gialloreti, N. Specchio, Mirte Scheper, 2023, World journal of pediatrics : WJP.

mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment.

A. Vezzani, T. Ravizza, Rossella Di Sapia, 2024, Nature reviews. Neuroscience.

Loss of maturity and homeostatic functions in Tuberous Sclerosis Complex-derived astrocytes

J. Anink, A. Mühlebner, T. Zimmer, 2023, Frontiers in cellular neuroscience.

Astroglial calcium signaling and homeostasis in tuberous sclerosis complex

J. Anink, A. Mühlebner, N. Filigheddu, 2024, Acta neuropathologica.